Pictet Asset Management Holding Sa Nurix Therapeutics, Inc. Transaction History
Pictet Asset Management Holding Sa
- $85.6 Billion
- Q2 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,173,518 shares of NRIX stock, worth $32 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,173,518
Previous 726,941
61.43%
Holding current value
$32 Million
Previous $10.7 Million
129.19%
% of portfolio
0.03%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding NRIX
# of Institutions
185Shares Held
67.3MCall Options Held
40.9KPut Options Held
106K-
Black Rock Inc. New York, NY6.82MShares$186 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.42MShares$120 Million6.02% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.99MShares$109 Million2.73% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$106 Million1.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$98.7 Million0.0% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $1.28B
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...